Art. 81 Directive (EU) 2001/83

In forcesince 30 Apr 2004cited 16×

With regard to the supply of medicinal products to pharmacists and persons authorised or entitled to supply medicinal products to the public, Member States shall not impose upon the holder of a distribution authorisation which has been granted by another Member State any obligation, in particular public service obligations, more stringent than those they impose on persons whom they have themselves authorised to engage in equivalent activities.

The holder of a marketing authorisation for a medicinal product and the distributors of the said medicinal product actually placed on the market in a Member State shall, within the limits of their responsibilities, ensure appropriate and continued supplies of that medicinal product to pharmacies and persons authorised to supply medicinal products so that the needs of patients in the Member State in question are covered.

The arrangements for implementing this Article should, moreover, be justified on grounds of public health protection and be proportionate in relation to the objective of such protection, in compliance with the Treaty rules, particularly those concerning the free movement of goods and competition.

The 10 that are cited most themselves, of 16.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Second Chamber), 28 June 2012. Fabio Caronna.Decisioninterprets

    This reference for a preliminary ruling concerns the interpretation of Articles 76 to 84 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for …

    28 Jun 2012 · 62011CJ0007

  • Beleidsregel aanhouden geneesmiddelenvoorradenLaw

    … voldoen aan de vraag naar geneesmiddelen van degenen die bevoegd zijn geneesmiddelen ter hand te stellen. Hiermee is artikel 81, tweede alinea, van Richtlijn 2001/83/EG van het Europees Parlement en de Raad van 6 november 2001 tot …

  • Opinion of Advocate General Bot delivered on 12 June 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egéDecision

    Article 81 of that directive states: ‘With regard to the supply of medicinal products to pharmacists and persons authorised or entitled to supply medicinal products to the public, Member States shall not impose upon the holder of a …

    12 Jun 2019 · 62018CC0222

  • Judgment of the Court (Fifth Chamber) of 18 September 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egDecision

    Moreover, although Directive 2001/83, and in particular Articles 79 to 82 thereof, harmonised the minimum requirements to be satisfied by applicants for and holders of an authorisation for the wholesale distribution of medicinal products …

    18 Sep 2019 · 62018CJ0222

  • Regulation (EU) 2022/123Law

    … 67).] oznámit členskému státu ukončení uvádění léčivého přípravku na jeho trh, ani povinnost podle článku 81 směrnice 2001/83/ES, podle níž musí držitelé rozhodnutí o registraci a distributoři zajistit …

  • Judgment of the Court (Grand Chamber) of 16 September 2008. Sot. Lélos kai Sia EE and Others v GlaxoSmithKline AEVE Farmakeftikon Proïonton,Decision

    It is true that in Greece, as is apparent from paragraph 8 of this judgment, national legislation places pharmaceuticals wholesalers under an obligation to supply the needs of a defined geographical area with a range of pharmaceutical …

    16 Sep 2008 · 62006CJ0468

  • Opinion of Mr Advocate General Jacobs delivered on 28 October 2004. Synetairismos Farmakopoion Aitolias & Akarnanias (Syfait) and Others v GDecision

    The second paragraph of Article 81 of Directive 2001/83 on the Community code relating to medicinal products for human use also now imposes the following obligation on pharmaceutical producers and their distributors: ‘The holder of a …

    28 Oct 2004 · 62003CC0053

  • Opinion of Advocate General Szpunar delivered on 3 March 2015. Abcur AB v Apoteket Farmaci AB and Apoteket AB.Decision

    In this context, for the purposes of Article 3(1) and (2), I would like to draw the Court’s attention to the Commission’s definition, in its written observations, of a pharmacy as a physical facility with the right to sell, supply, …

    3 Mar 2015 · 62013CC0544

  • Opinion of Mr Advocate General Ruiz-Jarabo Colomer delivered on 1 April 2008. Sot. Lélos kai Sia EE and Others v GlaxoSmithKline AEVE FarmakDecision

    1 Apr 2008 · 62006CC0468